- In September 2024, Uppsala University introduced a flexible stent aimed at reducing complications in coronary artery surgery. The stent was tested in the Infinity-Swedeheart study, which included 2,400 patients across 20 Swedish hospitals. The study compared this innovative stent with the traditional Resolute Onyx stent and holds potential to improve patient recovery and long-term outcomes in cardiac surgery
- In August 2024, Sahajanand Medical Technologies (SMT) completed patient enrollment for the Tuxedo 2 clinical trial in India. This pivotal trial is focused on assessing the safety and efficacy of the Supraflex Cruz Drug-Eluting Stent (DES) in diabetic patients suffering from multivessel coronary artery disease (CAD)
- In May 2024, Abbott launched the XIENCE Sierra Everolimus Eluting Coronary Stent System in India. This advanced stent offers enhanced safety for complex cases and is designed to treat patients with blocked coronary arteries, contributing to improved outcomes in angioplasty procedures
- In March 2024, Silk Road Medical, Inc. launched the Tapered ENROUTE Transcarotid Stent System in the U.S., primarily for use in hospitals. The new tapered configurations are part of the company’s broader portfolio, which enhances the flexibility of its carotid solutions, providing physicians with more options to address individual patient anatomy
- In February 2021, Cardiovascular Systems Inc. announced a partnership with Chansu Vascular Technologies, LLC to develop peripheral and coronary drug-coated balloons for use in drug-eluting stents
